Search clinical trials for: ALLN-177
Total 256252 results
-
Allena PharmaceuticalsCompletedNephrolithiasis | Kidney Stones | Hyperoxaluria | Secondary Hyperoxaluria | Dietary HyperoxaluriaUnited States
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science UniversityNot yet recruitingAnatomic Stage IV Breast Cancer AJCC v8 | Prognostic Stage IV Breast Cancer AJCC v8 | Recurrent Breast Carcinoma | Metastatic Breast CarcinomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnMetastatic Adrenal Gland Pheochromocytoma | Stage III Thyroid Gland Medullary Carcinoma AJCC v8 | Stage IV Thyroid Gland Medullary Carcinoma AJCC v8 | Locally Advanced Adrenal Gland Pheochromocytoma | Locally Advanced Paraganglioma | Metastatic Paraganglioma | Metastatic Parathyroid Gland Carcinoma and other conditionsUnited States
-
Allena PharmaceuticalsCompletedEnteric Hyperoxaluria | Primary Hyperoxaluria | HyperoxalemiaUnited States, United Kingdom, Germany
-
Allena PharmaceuticalsCompletedEnteric HyperoxaluriaUnited States, Spain, United Kingdom, Germany, Canada, Italy, France
-
Allena PharmaceuticalsCompletedNephrolithiasis | Kidney Stones | Hyperoxaluria | Secondary Hyperoxaluria | Dietary HyperoxaluriaUnited States
-
Instituto Nacional de Cancer, BrazilUnknown
-
Radboud University Medical CenterDutch Cancer SocietyCompletedAdenoid Cystic Carcinoma | Salivary Gland Cancer | Salivary Duct CarcinomaNetherlands
-
University Health Network, TorontoCancer Care Ontario; Ozmosis Research Inc.; Canadian Molecular Imaging Probe...Active, not recruitingNeuroendocrine TumorsCanada
-
Advanced Imaging Projects, LLCUniversity of Witwatersrand, South Africa; Postgraduate Institute of Medical...Not yet recruitingBreast Cancer Stage IVIndia, South Africa
-
Lantheus Medical ImagingPOINT BiopharmaAvailableCastration-Resistant Prostatic CancerUnited States
-
Novartis PharmaceuticalsCompletedNeuroendocrine TumorUnited States
-
Advanced Accelerator ApplicationsActive, not recruitingNeuroendocrine TumorsUnited Kingdom, Portugal, Spain, France, United States
-
Allena PharmaceuticalsTerminatedEnteric HyperoxaluriaUnited States, Spain, United Kingdom, Portugal, Romania, Canada, Austria, Belgium, Brazil, Croatia, France, Germany, Italy, Mexico, Russian Federation, Switzerland
-
University of IowaNovartisNot yet recruitingNeuroendocrine Tumors | Neuroendocrine Tumor Grade 2 | Neuroendocrine Tumor Grade 1United States
-
University College, LondonNot yet recruitingMedullary Thyroid Carcinoma | Bronchial and Thymic Neuroendocrine Tumour | Paraganglioma/ Phaeochromocytoma | Those Requiring Repeat Peptide Receptor Radionuclide Therapy
-
Marnix LamCompletedNeuroendocrine Tumors | Liver MetastasesNetherlands
-
Bivision Pharmaceuticals, Inc.Recruiting
-
Nanjing First Hospital, Nanjing Medical UniversityUnknownMetastatic Castration-resistant Prostate CancerChina
-
POINT BiopharmaActive, not recruitingSoft Tissue Sarcoma | Colorectal Cancer | Esophageal Cancer | Cholangiocarcinoma | Head and Neck Squamous Cell Carcinoma | Pancreatic Ductal Adenocarcinoma | Melanoma (Skin)United States, Canada
-
AHS Cancer Control AlbertaCross Cancer InstituteActive, not recruiting
-
Ralph NULL SalloumChildren's Hospital Medical Center, CincinnatiRecruitingHigh Grade Glioma | Medulloblastoma | Meningioma | Anaplastic Ependymoma | Recurrent Malignant Glioma | Recurrent Medulloblastoma | Refractory Malignant Glioma | Refractory Medulloblastoma | Recurrent Diffuse Intrinsic Pontine Glioma | Recurrent Primary Central Nervous System Neoplasm | Refractory Primary... and other conditionsUnited States
-
Cellbion Co., Ltd.Recruiting
-
Jonsson Comprehensive Cancer CenterPOINT BiopharmaActive, not recruitingProstate Adenocarcinoma | Stage IVB Prostate Cancer AJCC v8 | Oligometastatic Prostate Carcinoma | Recurrent Prostate AdenocarcinomaUnited States
-
POINT Biopharma, a wholly owned subsidiary of Eli...Active, not recruitingMetastatic Castration-Resistant Prostate CancerUnited States, Canada, Netherlands, Sweden, France, United Kingdom
-
Peter MacCallum Cancer Centre, AustraliaRecruitingProstate Cancer | Metastatic Castration-resistant Prostate Cancer | mCRPCAustralia
-
Lawson Health Research InstituteActive, not recruiting
-
AHS Cancer Control AlbertaRecruitingCarcinoma, NeuroendocrineCanada
-
Providence Health & ServicesExelixis; Advanced Accelerator Applications SAActive, not recruitingNeuroendocrine TumorsUnited States
-
Wakayama Medical UniversityHuman Genome Center, Institute of Medical Science, University of TokyoUnknown
-
Radboud University Medical CenterCompleted
-
Radboud University Medical CenterCompletedMetastatic Clear Cell Renal Cell CarcinomaNetherlands
-
Allena PharmaceuticalsCompletedNephrolithiasis | HyperoxaluriaUnited States
-
David BushnellNational Cancer Institute (NCI); National Institutes of Health (NIH); Progenics...WithdrawnNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine TumorUnited States
-
Tine Gregersen, MDRecruitingNeuroendocrine NeoplasmDenmark
-
National Cancer Institute (NCI)RecruitingMetastatic Midgut Neuroendocrine Tumor | Unresectable Midgut Neuroendocrine Tumor | Metastatic Midgut Neuroendocrine Tumor G1 | Metastatic Midgut Neuroendocrine Tumor G2United States, Canada
-
National Cancer Institute (NCI)Recruiting
-
Imperial College LondonAdvanced Accelerator Applications International SARecruiting
-
National Cancer Institute (NCI)RecruitingStage IV Prostate Cancer AJCC v8 | Metastatic Prostate Small Cell Neuroendocrine Carcinoma | Metastatic Prostate Adenocarcinoma With Neuroendocrine Differentiation | Metastatic Prostate Neuroendocrine CarcinomaUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Digestive System Neuroendocrine Neoplasm | Metastatic Neuroendocrine TumorUnited States
-
HeNan Sincere Biotech Co., LtdCompleted
-
National Cancer Institute (NCI)Active, not recruiting
-
TakedaWithdrawn
-
Jin Chen-jinCompletedAcute Central Serous ChorioretinopathyChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingAlzheimer's DiseaseChina
-
Novartis PharmaceuticalsActive, not recruitingSomatostatin Receptor-positive GEP-NETKorea, Republic of
-
Stanford UniversityNovartis PharmaceuticalsRecruitingGastroenteropancreatic Neuroendocrine TumorUnited States
-
Kowa Research Institute, Inc.Completed
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Recruiting
-
TakedaTerminatedAttention-Deficit/Hyperactivity DisorderUnited States